MyFinsight
Home
Blog
About
Contact
Proceeds from standby
equity purchase...
$1,644,588
Net cash provided by
financing activities
$1,644,588
Net change in cash
and cash...
$1,100,754
Canceled cashflow
$543,834
Increase in accrued
expenses and other...
$217,158
Warrants
issued/(cancelled) to consultants
-$206,864
Imputed interest -
related party
$18,395
Increase in accounts
payable
$14,977
Decrease in operating
lease right-of-use,...
-$13,828
Fair value of options
issued for services
$10,157
Depreciation expense
$6,222
Decrease prepaid
expenses
-$4,176
Net cash used in
operating activities
-$529,718
Net cash provided by
investing activities
-$14,116
Canceled cashflow
$491,777
Net loss
-$942,720
Purchase of fixed assets
$14,116
(increase) in inventory
$45,240
Net change in
unrealized appreciation...
-$20,408
Decrease in operating
lease liabilities,...
-$13,127
Back
Back
Cash Flow
Kraig Biocraft Laboratories, Inc. (KBLB)
Kraig Biocraft Laboratories, Inc. (KBLB)
source: myfinsight.com